Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index; 11 of the 22 sources its claims cite were checked for support.

S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3

Open access

Abstract

Significance: Recent exome sequencing studies have uncovered high-frequency histone H3 driver mutations in pediatric cancers. Previous studies have shown that lysine to methionine histone mutations are potent inhibitors of their respective lysine methyltransferases. However, an in-depth understanding of this inhibition was limited by the lack of structural and kinetic information. This study investigates the biochemical and biophysical parameters of lysine to methionine histone mutants using the methyltransferase G9a and H3K9M as a model system. Structural and functional experiments conclude that the methyltransferase cofactor S -adenosyl methionine is required for binding of G9a to the mutant histone.

Overview

CoChat Summary

TL;DR

The histone H3K9M oncohistone inhibits the H3K9 methyltransferase G9a by occupying its active site, but stable G9a–H3K9M interaction requires the cofactor S-adenosyl methionine (SAM). The data support a model in which SAM-bound SET domain methyltransferases are sequestered by K-to-M oncohistones, causing global loss of histone methylation.

Key findings

  • H3K9M and K9I transgenes reduced cellular H3K9me2/3, whereas K9A, K9L, and K9R showed little or no reduction; ectopically expressed histones made up less than 5% of total histone H3, indicating a dominant-negative effect.
  • Cocrystal structures showed the K9M residue occupies the G9a active site and adopts a conformation virtually identical to the dimethyl-lysine product peptide; SAM was fully occupied in the cofactor pocket even without added SAM, and excess SAH did not displace it.
  • SAM is necessary for stable G9a–K9M/Nle binding: G9a bound SAM with a Kd of 2.6 μM, did not bind K9Nle after dialysis, but bound K9Nle with a Kd of 0.032 μM when 1 mM SAM was added; SAH did not promote binding.
  • Kinetics with K9Nle showed competitive inhibition with respect to H3 peptide (Kis = 1.6 ± 0.2 nM) and uncompetitive inhibition with respect to SAM (Kii = 66 ± 5 nM).

Methods

  • X-ray cocrystallization of G9a-SET with H3K9M, H3K9Nle, and H3K9A peptides; diffraction data collected at Argonne Advanced Photon Source and Canadian Light Source; structures solved by molecular replacement using apo-G9a (PDB 2O8J), with the H3K9M complex at 1.85-Å resolution.
  • In vitro histone methyltransferase assays using H3 1-20 peptide (23 μM), 25 nM G9a-SET, and 50 μM SAM; additional binding and kinetic analyses by differential scanning fluorimetry, isothermal titration calorimetry, peptide pulldown, and Michaelis-Menten/Lineweaver-Burk kinetics.
  • Cellular assays in lentivirus-transduced 293T/293 cells expressing H3.3 WT or K9X transgenes, with immunoblot analysis of whole-cell extracts and affinity-purified heterotypic mononucleosomes.

Limitations

  • The paper does not include a dedicated limitations section.
  • Evident from the text: the study uses G9a as a model system, so conclusions about other SET domain methyltransferases and PRC2 are extrapolations.
  • Kinetic assays used K9Nle rather than K9M because methionine oxidation decreases potency, and ITC analysis of K9 substrate was complicated by turnover at high substrate/enzyme concentrations.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.1605523113

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

8 Valid · 0 Not valid · 3 Not checked · 48 Own results and interpretations

31 more claims

Create a free account to see all 59 claims and to verify the 3 references still open.

See all claims — free account
  • Probably not a substantial claim. 9
  • It may state two separate claims as one. 17

Create a free account to see these claims.

Citations

Cites

Show all 26 references

Cited by

See all 93

Metadata

Authors
Jayaram, H., Hoelper, D., Jain, S. U., Cantone, N., Lundgren, S. M., Poy, F., Allis, C. D., Cummings, R., Bellon, S., & Lewis, P. W.
Affiliations
  • Constellation Pharmaceuticals (United States) (US)
  • University of Wisconsin–Madison (US)
  • Rockefeller University (US)
Venue
Proceedings of the National Academy of Sciences
Published
2016-05-16
Volume
113
Issue
22
Pages
6182-6187
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2403631776
Cited by
92
References
26
Citations by year
2026: 8 · 2025: 10 · 2024: 4 · 2023: 5 · 2022: 13 · 2021: 4 · 2020: 11 · 2019: 14 · 2018: 10 · 2017: 10 · 2016: 3
FWCI
6.41
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
Funders
  • HHS | NIH | National Cancer Institute (P01CA196539)
  • Starr Cancer Consortium (SCC I6-A614)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords
S-adenosylmethionine, G9a, histone H3 lysine 9 methylation, oncohistones, SET domain methyltransferase, competitive inhibition, uncompetitive inhibition, ternary complex, co-crystal structure
MeSH terms
Histones, Humans, Lysine, Methionine, Mutation, Peptide Fragments, Histone-Lysine N-Methyltransferase, S-Adenosylmethionine, Substrate Specificity, Crystallography, X-Ray

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3. https://app.cochat.ai/papers/10.1073/pnas.1605523113
The paper
Jayaram, H., Hoelper, D., Jain, S. U., Cantone, N., Lundgren, S. M., Poy, F., Allis, C. D., Cummings, R., Bellon, S., & Lewis, P. W. (2016). S -adenosyl methionine is necessary for inhibition of the methyltransferase G9a by the lysine 9 to methionine mutation on histone H3. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1605523113

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.